Free Trial
NYSE:NVST

Envista (NVST) Stock Price, News & Analysis

$16.99
-0.23 (-1.34%)
(As of 06/18/2024 ET)
Today's Range
$16.90
$17.40
50-Day Range
$16.99
$20.62
52-Week Range
$16.90
$36.14
Volume
2.86 million shs
Average Volume
2.10 million shs
Market Capitalization
$2.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.86

Envista MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.92 Rating Score
Upside/​Downside
52.2% Upside
$25.86 Price Target
Short Interest
Bearish
7.09% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.94
Upright™ Environmental Score
News Sentiment
0.49mentions of Envista in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.01%
From $1.23 to $1.39 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.82 out of 5 stars

Medical Sector

210th out of 913 stocks

Dental Equipment & Supplies Industry

2nd out of 3 stocks

NVST stock logo

About Envista Stock (NYSE:NVST)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

NVST Stock Price History

NVST Stock News Headlines

Historic NVIDIA partnership could send this tiny AI stock soaring...
After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's next?
Tracking Tweedy Browne Portfolio - Q1 2024 Update
Historic NVIDIA partnership could send this tiny AI stock soaring...
After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's next?
Goldman Sachs Keeps Their Sell Rating on Envista Holdings (NVST)
Unveiling 4 Analyst Insights On Envista Holdings
Envista Reports First Quarter 2024 Results
Envista Reports First Quarter 2024 Results
Here's what Wall Street expects from Envista's earnings
Envista Holdings Corporation (NVST)
Envista Names Paul Keel CEO
Envista Announces CEO Appointment
See More Headlines
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/01/2024
Today
6/19/2024
Next Earnings (Estimated)
8/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Employees
12,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.86
High Stock Price Target
$45.00
Low Stock Price Target
$17.50
Potential Upside/Downside
+52.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.92
Research Coverage
12 Analysts

Profitability

Net Income
$-100,200,000.00
Pretax Margin
-2.94%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$2.45 per share
Book Value
$24.35 per share

Miscellaneous

Free Float
169,624,000
Market Cap
$2.92 billion
Optionable
Optionable
Beta
1.34
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

NVST Stock Analysis - Frequently Asked Questions

Should I buy or sell Envista stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Envista in the last twelve months. There are currently 3 sell ratings, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" NVST shares.
View NVST analyst ratings
or view top-rated stocks.

What is Envista's stock price target for 2024?

12 equities research analysts have issued twelve-month price objectives for Envista's stock. Their NVST share price targets range from $17.50 to $45.00. On average, they anticipate the company's stock price to reach $25.86 in the next year. This suggests a possible upside of 52.2% from the stock's current price.
View analysts price targets for NVST
or view top-rated stocks among Wall Street analysts.

How have NVST shares performed in 2024?

Envista's stock was trading at $24.06 on January 1st, 2024. Since then, NVST stock has decreased by 29.4% and is now trading at $16.99.
View the best growth stocks for 2024 here
.

Are investors shorting Envista?

Envista saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 12,190,000 shares, an increase of 35.4% from the May 15th total of 9,000,000 shares. Based on an average trading volume of 2,140,000 shares, the short-interest ratio is presently 5.7 days.
View Envista's Short Interest
.

When is Envista's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024.
View our NVST earnings forecast
.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) announced its quarterly earnings results on Wednesday, May, 1st. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.31 by $0.05. The business had revenue of $623.60 million for the quarter, compared to the consensus estimate of $634.85 million. Envista had a positive trailing twelve-month return on equity of 5.84% and a negative net margin of 4.70%. The business's quarterly revenue was down .6% on a year-over-year basis. During the same period in the previous year, the business earned $0.38 earnings per share.

What ETFs hold Envista's stock?

ETFs with the largest weight of Envista (NYSE:NVST) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE).iShares U.S. Medical Devices ETF (IHI).

What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

Envista (NVST) raised $603 million in an IPO on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Who are Envista's major shareholders?

Envista's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.97%), Ariel Investments LLC (5.17%), Nuance Investments LLC (2.78%), Swedbank AB (1.45%), Tweedy Browne Co LLC (0.57%) and Paradice Investment Management LLC (0.53%). Insiders that own company stock include Amir Aghdaei, Curt W Bludworth, Eric Conley, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance, Mischa Reis and Stephen Keller.
View institutional ownership trends
.

How do I buy shares of Envista?

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NVST) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners